Tillkännagivande • May 20
Continental Chemicals Limited to Report Q4, 2026 Results on May 30, 2026 Continental Chemicals Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026 Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹74.08, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 25x in the IT industry in India. Total loss to shareholders of 11% over the past three years. Reported Earnings • Jan 13
Third quarter 2026 earnings released: EPS: ₹0.60 (vs ₹0.43 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.60 (up from ₹0.43 in 3Q 2025). Net income: ₹1.34m (up 38% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Tillkännagivande • Jan 05
Continental Chemicals Limited Announces Resignation of Navneet Kumar as Chief Financial Officer, Effective January 14, 2026 Continental Chemicals Limited announced that Mr. Navneet Kumar has resigned from the position of Chief Financial Officer. Mr. Navneet Kumar submitted his resignation on December 13, 2025 due to personal reasons in view of his decision to pursue another career opportunity, with the resignation effective from January 14, 2026. The company submitted intimation in this regard to BSE on December 13, 2025. Tillkännagivande • Jan 03
Continental Chemicals Limited to Report Q3, 2026 Results on Jan 12, 2026 Continental Chemicals Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Jan 12, 2026 New Risk • Nov 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹2.3m revenue, or US$26k). Market cap is less than US$10m (₹157.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change). Tillkännagivande • Nov 05
Continental Chemicals Limited to Report Q2, 2026 Results on Nov 13, 2025 Continental Chemicals Limited announced that they will report Q2, 2026 results on Nov 13, 2025 Tillkännagivande • Aug 26
Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025 Continental Chemicals Limited, Annual General Meeting, Sep 20, 2025, at 16:00 Indian Standard Time. Reported Earnings • Aug 09
First quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.50 in 1Q 2025) First quarter 2026 results: EPS: ₹0.64 (up from ₹0.50 in 1Q 2025). Net income: ₹1.44m (up 29% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Tillkännagivande • Aug 06
Continental Chemicals Limited Announces Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee Continental Chemicals Limited at its board meeting held on August 6, 2025 approved Reconstitution of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee. In reference to the above mentioned subject, please take note that the Board of Directors of the Company has made the following changes in the Composition of the Committees. Audit Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Naresh Kumar Chibba - Member Mr. Gaurav Sachdeva - Member. Changed Composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba - Member; Mr. Gaurav Sachdeva - Member. Nomination and Remuneration Committee: Previous Composition: Mr. Raghav Nathani - Chairperson; Mr. Gaurav Sachdeva Member; Ms.Sunaina Chibba- Member. Ms. Sunaina Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Gaurav Sachdeva Member; Ms. Sunaina Chibba-- Member. Stakeholders Relationship Committee: Previous Composition: Mr. Raghav Nathani -Chairperson; Mr. Naresh Kumar Chibba - Member Mr. Aditya Vikram Chibba- Member. Changed composition: Mrs. Parul Suraiya- Chairperson; Mr. Naresh Kumar Chibba- Member; Mr. Aditya Vikram Chibba- Member. Tillkännagivande • Jul 30
Continental Chemicals Limited to Report Q1, 2026 Results on Aug 08, 2025 Continental Chemicals Limited announced that they will report Q1, 2026 results on Aug 08, 2025 Reported Earnings • May 18
Full year 2025 earnings released: EPS: ₹1.94 (vs ₹2.30 in FY 2024) Full year 2025 results: EPS: ₹1.94 (down from ₹2.30 in FY 2024). Revenue: ₹15.7m (up 271% from FY 2024). Net income: ₹4.36m (down 16% from FY 2024). Profit margin: 28% (down from 122% in FY 2024). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. New Risk • May 18
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 28% Last year net profit margin: 122% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Revenue is less than US$1m (₹16m revenue, or US$184k). Market cap is less than US$10m (₹164.6m market cap, or US$1.92m). Minor Risk Profit margins are more than 30% lower than last year (28% net profit margin). Tillkännagivande • May 10
Continental Chemicals Limited to Report Q4, 2025 Results on May 17, 2025 Continental Chemicals Limited announced that they will report Q4, 2025 results on May 17, 2025 Reported Earnings • Feb 05
Third quarter 2025 earnings released: EPS: ₹0.43 (vs ₹0.78 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.43 (down from ₹0.78 in 3Q 2024). Net income: ₹975.0k (down 44% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Tillkännagivande • Jan 28
Continental Chemicals Limited to Report Q3, 2025 Results on Feb 03, 2025 Continental Chemicals Limited announced that they will report Q3, 2025 results on Feb 03, 2025 Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹86.25, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 36x in the IT industry in India. Total loss to shareholders of 75% over the past three years. Tillkännagivande • Nov 05
Continental Chemicals Limited to Report Q2, 2025 Results on Nov 12, 2024 Continental Chemicals Limited announced that they will report Q2, 2025 results on Nov 12, 2024 Valuation Update With 7 Day Price Move • Oct 11
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹90.02, the stock trades at a trailing P/E ratio of 38.8x. Average trailing P/E is 41x in the IT industry in India. Total loss to shareholders of 77% over the past three years. Tillkännagivande • Aug 26
Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024 Continental Chemicals Limited, Annual General Meeting, Sep 20, 2024, at 16:00 Indian Standard Time. Reported Earnings • Aug 11
First quarter 2025 earnings released: EPS: ₹0.50 (vs ₹0.50 in 1Q 2024) First quarter 2025 results: EPS: ₹0.50 (in line with 1Q 2024). Net income: ₹1.12m (flat on 1Q 2024). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Tillkännagivande • Aug 01
Continental Chemicals Limited to Report Q1, 2025 Results on Aug 09, 2024 Continental Chemicals Limited announced that they will report Q1, 2025 results on Aug 09, 2024 Reported Earnings • May 19
Full year 2024 earnings released: EPS: ₹2.30 (vs ₹1.11 in FY 2023) Full year 2024 results: EPS: ₹2.30 (up from ₹1.11 in FY 2023). Revenue: ₹15.7m (up 259% from FY 2023). Net income: ₹5.18m (up 108% from FY 2023). Profit margin: 33% (down from 57% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth. New Risk • May 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹3.7m revenue, or US$45k). Market cap is less than US$10m (₹163.4m market cap, or US$1.96m). Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change). Reported Earnings • Jan 23
Third quarter 2024 earnings released: EPS: ₹0.78 (vs ₹0.66 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.78 (up from ₹0.66 in 3Q 2023). Revenue: ₹4.47m (up 145% from 3Q 2023). Net income: ₹1.75m (up 18% from 3Q 2023). Profit margin: 39% (down from 81% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 70% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 16
Continental Chemicals Limited to Report Q3, 2024 Results on Jan 22, 2024 Continental Chemicals Limited announced that they will report Q3, 2024 results on Jan 22, 2024 Tillkännagivande • Nov 01
Continental Chemicals Limited to Report Q2, 2024 Results on Nov 09, 2023 Continental Chemicals Limited announced that they will report Q2, 2024 results on Nov 09, 2023 Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹73.60, the stock trades at a trailing P/E ratio of 66.4x. Average trailing P/E is 36x in the IT industry in India. Total returns to shareholders of 287% over the past three years. Reported Earnings • Aug 26
Full year 2023 earnings released: EPS: ₹1.11 (vs ₹0.27 in FY 2022) Full year 2023 results: EPS: ₹1.11 (up from ₹0.27 in FY 2022). Revenue: ₹12.7m (up 165% from FY 2022). Net income: ₹2.49m (up 316% from FY 2022). Profit margin: 20% (up from 13% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Aug 26
Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023 Continental Chemicals Limited, Annual General Meeting, Sep 20, 2023, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31 March 2023, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to consider and appoint a director in place of Mr. Aditya Vikram Chibba, who retires by rotation and being eligible, offers himself for re-appointment; to consider resolution to be passed under Section 180(1) of the Companies Act, 2013 to sell, lease, transfer, convey, assign or otherwise to dispose; and to consider any other matters of the company's immovable properties. New Risk • Aug 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹4.4m revenue, or US$53k). Market cap is less than US$10m (₹150.2m market cap, or US$1.82m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (7.8% average weekly change). Tillkännagivande • Aug 01
Continental Chemicals Limited Appoints Navneet Kumar as the Chief Financial Officer Continental Chemicals Limited Board of Directors of the Company in their Board meeting held i.e., 31 July, 2023 appointed Mr. Navneet Kumar as the Chief Financial Officer of the company. effective from 31 July, 2023. Brief profile: Mr. Navneet Kumar is appointed as the -- chief Financial Officer of the company in the capacity of Key Managerial Personnel w.e.f 31 July, 2023, Mr. Navneet Kumar is appointed as per the terms and conditions contained in his appointment letter. Mr. Navneet Kumar holds MBA Degree in Finance & Marketing from the prestigious University UPTU, Lucknow. He also have rich working experience in Finance and Accounts. Tillkännagivande • Jul 25
Continental Chemicals Limited to Report Q1, 2024 Results on Jul 31, 2023 Continental Chemicals Limited announced that they will report Q1, 2024 results on Jul 31, 2023 Tillkännagivande • May 20
Continental Chemicals Limited to Report Q4, 2023 Results on May 29, 2023 Continental Chemicals Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 29, 2023 Tillkännagivande • Jan 28
Continental Chemicals Limited to Report Q3, 2023 Results on Feb 04, 2023 Continental Chemicals Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 04, 2023 Tillkännagivande • Jan 18
Continental Chemicals Limited Announces Resignation of Nitesh Rai as Chief Financial Officer Continental Chemicals Limited announced that Mr. Nitesh Rai has resigned from the post of CFO of the Continental Chemicals Limited on 16 January, 2023 due to personal reasons. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 13
Second quarter 2023 earnings released: EPS: ₹0.31 (vs ₹0.32 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.31 (down from ₹0.32 in 2Q 2022). Revenue: ₹3.24m (up 95% from 2Q 2022). Net income: ₹685.0k (down 5.0% from 2Q 2022). Profit margin: 21% (down from 44% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 174 percentage points per year, which is a significant difference in performance. Tillkännagivande • Nov 05
Continental Chemicals Limited to Report Q2, 2023 Results on Nov 11, 2022 Continental Chemicals Limited announced that they will report Q2, 2023 results on Nov 11, 2022 Tillkännagivande • Aug 28
Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022 Continental Chemicals Limited, Annual General Meeting, Sep 20, 2022, at 16:00 Indian Standard Time. Agenda: To receive, consider and adopt the Board's Report for the year ended 31% March 2022, audited Statement of Profit and Loss for the year, Balance Sheet as on that date, and the Report of the Auditors thereon; to appoint a director in place of Ms. Sunaina Chibba, who retires by rotation and being eligible, offers herself for re-appointment; to consider and approve reappointment of Mr. Naresh Kumar Chibba as Managing Director of the Company; and to consider other issues. Reported Earnings • Aug 10
First quarter 2023 earnings released: EPS: ₹0.35 (vs ₹0.15 in 1Q 2022) First quarter 2023 results: EPS: ₹0.35 (up from ₹0.15 in 1Q 2022). Revenue: ₹3.16m (up 165% from 1Q 2022). Net income: ₹797.0k (up 141% from 1Q 2022). Profit margin: 25% (down from 28% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 187 percentage points per year, which is a significant difference in performance. Tillkännagivande • Jul 31
Continental Chemicals Limited to Report Q1, 2023 Results on Aug 08, 2022 Continental Chemicals Limited announced that they will report Q1, 2023 results on Aug 08, 2022 Tillkännagivande • Jul 01
Continental Chemicals Limited Appoints Mr. Nitesh Rai as the Chief Financial Officer, With Effect from June 30, 2022 Continental Chemicals Limited appointed Mr. Nitesh Rai as the Chief Financial Officer of the company. Mr. Nitesh Rai is appointed as the chief Financial Officer of the company in the capacity of Key Managerial Personnel with effect from June 30, 2022, Mr. Nitesh Rai is appointed as per the terms and conditions contained in his appointment letter. Mr. Nitesh Rai holds graduation degree in B.com (Hons) from the prestigious college of Delhi university. He also have rich working experience in Finance and Accounts. Tillkännagivande • Jun 09
Continental Chemicals Limited Announces the Resignation of Puneet Kumar as Chief Financial Officer (CFO) Continental Chemicals Limited announced the resignation of Puneet Kumar as Chief Financial Officer (CFO), with effect from June 7, 2022, due to personal reasons. Tillkännagivande • May 16
Continental Chemicals Limited to Report Q4, 2022 Results on May 21, 2022 Continental Chemicals Limited announced that they will report Q4, 2022 results on May 21, 2022 Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 17
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹0.21 (up from ₹0.02 in 3Q 2021). Revenue: ₹3.51m (up 294% from 3Q 2021). Net income: ₹467.0k (up ₹422.0k from 3Q 2021). Profit margin: 13% (up from 5.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 155% per year, which means it is well ahead of earnings. Tillkännagivande • Jan 30
Continental Chemicals Limited to Report Q3, 2022 Results on Feb 05, 2022 Continental Chemicals Limited announced that they will report Q3, 2022 results on Feb 05, 2022 Board Change • Dec 15
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Nov 11
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Oct 25
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Akshat Bhaskar was the last independent director to join the board, commencing their role in 2014. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 03
First quarter 2022 earnings released: EPS ₹0.15 (vs ₹0.05 in 1Q 2021) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹2.21m (up 350% from 1Q 2021). Net income: ₹331.0k (up 176% from 1Q 2021). Profit margin: 15% (down from 25% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 88% per year, which means it is well ahead of earnings. Executive Departure • Jul 23
Company Secretary & Compliance Officer Bhawna Gupta has left the company On the 15th of July, Bhawna Gupta's tenure as Company Secretary & Compliance Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Bhawna's name. Bhawna is the only executive to leave the company over the last 12 months. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improved over the past week After last week's 16% share price gain to ₹30.45, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 31x in the IT industry in India. Total returns to shareholders of 253% over the past three years. Reported Earnings • Jun 21
Full year 2021 earnings released: EPS ₹0.64 (vs ₹0.49 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹9.68m (up 210% from FY 2020). Net income: ₹1.43m (up 84% from FY 2020). Profit margin: 15% (down from 25% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improved over the past week After last week's 21% share price gain to ₹17.70, the stock trades at a trailing P/E ratio of 70.4x. Average trailing P/E is 29x in the IT industry in India. Total returns to shareholders of 116% over the past three years. Is New 90 Day High Low • Feb 10
New 90-day low: ₹13.36 The company is down 30% from its price of ₹19.00 on 12 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 20% over the same period. Reported Earnings • Feb 07
Third quarter 2021 earnings released: EPS ₹0.02 (vs ₹0.07 loss in 3Q 2020) Third quarter 2021 results: Net income: ₹45.0k (up ₹145.0k from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Feb 07
Continental Chemicals Limited Appoints Puneet Kumar as CFO Continental Chemicals Limited announced that, Mr. Puneet Kumar has been appointed as CFO of the company in the Board Meeting held on February 6, 2021 with effect from February 6, 2021. Tillkännagivande • Feb 01
Continental Chemicals Limited to Report Q3, 2021 Results on Feb 06, 2021 Continental Chemicals Limited announced that they will report Q3, 2021 results on Feb 06, 2021 Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₹15.55, the stock is trading at a trailing P/E ratio of 51.7x, down from the previous P/E ratio of 66.2x. This compares to an average P/E of 22x in the IT industry in India. Total returns to shareholders over the past three years are 153%. Tillkännagivande • Nov 27
Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020 Continental Chemicals Limited, Annual General Meeting, Dec 21, 2020, at 16:30 Indian Standard Time. Agenda: To receive, consider and adopt the Board's report for the year ended March 31, 2020, audited statement of profit and loss for the year, Balance Sheet as on that date, and report of the Auditors thereon; to appoint a Director in place of Ms. Sunaina Chibba (DIN: 00370454), who retires by rotation and being eligible, offers herself for re-appointment; and to consider Regularization of Mr. Aditya Vikram Chibba (DIN: 02838045) As Director of the Company, to consider and if thought fit, to pass, with or without modification. Tillkännagivande • Nov 07
Continental Chemicals Limited to Report Q2, 2021 Results on Nov 12, 2020 Continental Chemicals Limited announced that they will report Q2, 2021 results on Nov 12, 2020 
